Company Overview and News
KUALA LUMPUR: Hartalega Holdings Bhd , Fraser and Neave Holdings Bhd (F&N), Talam Transform Bhd , Sunway REIT, Eita Resources Bhd and Pasukhas Group Bhd are among the stocks to watch, according to JF Apex Research.
KUALA LUMPUR: Talam Transform Bhd advanced as much as 22.22% in early trade on Thursday after the company secured a construction contract worth RM36.55mil.
KUALA LUMPUR: Deleum, Talam Transform , Pestech International and Marine & General are among the stocks to watch on Thursday, according to JF Apex Research.
KUALA LUMPUR, July 28 ― Bursa Malaysia finished the week lower today on lack of market-moving catalysts, dealers said.
KUALA LUMPUR, July 27 — Bursa Malaysia finished at a three-week high today as investor sentiment was fuelled by firmer crude oil prices, along with the US Federal Reserve’s dovish stance on interest rate increase.
An investor monitors share market prices at a brokerage firm in Kuala Lumpur, Malaysia, August 24, 2015. — Reuters picKUALA LUMPUR, July 5 — Bursa Malaysia extended its yesterday’s loss to open lower today on lack of fresh catalysts following the close of Wall Street market on US Independence Day yesterday.
KUALA LUMPUR, Feb 17 — Bursa Malaysia extended yesterday's losses on continued selling pressure to open lower this morning in line with the softer overnight tone of US and European stock markets.
KUALA LUMPUR, Aug 12 — Bursa Malaysia ended higher today on persistent buying support in blue-chips, coupled with healthy regional sentiment, dealers said.
KUALA LUMPUR (Aug 12): The FBM KLCI rose 5.35 points or 0.3%, tracking Asian share market gains on China's economic stimulus expectation as crude oil prices rose.
KUALA LUMPUR (Aug 12): The FBM KLCI rose 0.22% at the midday break today and looked poised for a weekly gain, in line with the advance at most regional markets.
An investor monitors share market prices at a brokerage firm in Kuala Lumpur, Malaysia, August 24, 2015. — Reuters picKUALA LUMPUR, Aug 12 — Share prices on Bursa Malaysia remained in positive territory at mid-morning today on persistent buying support in blue-chip counters, dealers said.
KUALA LUMPUR (Aug 12): The FBM KLCI gained 0.29% at mid-morning today as most regional markets advanced in tandem with the firmer overnight close at Wall Street.
An investor monitors share market prices at a brokerage firm in Kuala Lumpur, Malaysia, August 24, 2015. — Reuters picKUALA LUMPUR, Aug 12 — Bursa Malaysia extended yesterday’s gains to open higher today on continued buying support in most of the heavyweight stocks, dealers said.
MarketWrap: The Dow Jones industrial average climbed to a nine-month high on Monday, in a market buoyed by Hasbro and Disney, as investors braced for a flurry of quarterly earnings reports through the week. - Reuters DJIA rose 0.6% to end the day at 18,004.16 points, the S&P 500 gained 0.65% to 2,094.34 and the Nasdaq added 0.44% to 4,960.02. Forex summary *The ringgit rises 0.67% to 3.9032 per US$ *It rises 0.
KUALA LUMPUR (March 31): Based on corporate announcements and news flow today, companies that may be in focus tomorrow (Friday, April 1) could include the following: MMC Corp, Gamuda, Pestech, WCT, Econpile, Texchem and Talam Transform.
2018-05-21 - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
2018-05-21 - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...